Eva Thomas
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 10
- Cancer Treatment and Pharmacology 7
- COVID-19 and healthcare impacts 2
- HER2/EGFR in Cancer Research 2
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Gabriel N. Hortobágyi (8 shared papers)Aman U. Buzdar (6 shared papers)Richard L. Theriault (5 shared papers)Thomas A. Buchholz (5 shared papers)S. Eva Singletary (4 shared papers)Nuhad K. Ibrahim (3 shared papers)Linda T. Vahdat (6 shared papers)Marjorie C. Green (3 shared papers)
- Journals
- Journal of Clinical Oncology (6 papers)Clinical Breast Cancer (3 papers)Cancer (2 papers)Supportive Care in Cancer (1 paper)JNCI Journal of the National Cancer Institute (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Eva Thomas
19 papers receiving 1.9k citations
Eva Thomas's Hit Papers
Peers
Comparison fields: 5 of 66
- Cancer Research 782
- Oncology 1.3k
- Radiology, Nuclear Medicine and Imaging 242
- Pathology and Forensic Medicine 129
- Cell Biology 118
Countries citing papers authored by Eva Thomas
This map shows the geographic impact of Eva Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Thomas more than expected).
Fields of papers citing papers by Eva Thomas
This network shows the impact of papers produced by Eva Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Thomas. The network helps show where Eva Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Eva Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer Hit paper breakdown → | 2005 | 913 |
| 2 | 2007 | 318 | |
| 3 | 2007 | 235 | |
| 4 | 2003 | 148 | |
| 5 | 2004 | 110 | |
| 6 | 2004 | 51 | |
| 7 | 2008 | 49 | |
| 8 | 2004 | 41 | |
| 9 | 2012 | 35 | |
| 10 | 2018 | 29 | |
| 11 | 2012 | 26 | |
| 12 | 2022 | 23 | |
| 13 | 2009 | 20 | |
| 14 | 2006 | 9 | |
| 15 | 2012 | 9 | |
| 16 | 1998 | 8 | |
| 17 | 2005 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2023 | 1 |
About Eva Thomas
Eva Thomas is a scholar working on Oncology, Cancer Research, Infectious Diseases, Genetics and Radiation, having authored 19 papers that have together received 2.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (7 papers), Cancer Treatment and Pharmacology (7 papers), COVID-19 and healthcare impacts (2 papers), HER2/EGFR in Cancer Research (2 papers), Chronic Lymphocytic Leukemia Research (1 paper), HIV/AIDS drug development and treatment (1 paper), Advanced Radiotherapy Techniques (1 paper) and Telemedicine and Telehealth Implementation (1 paper). The work is most often cited by research in Cancer Research (782 citations), Oncology (1.3k citations), Radiology, Nuclear Medicine and Imaging (242 citations), Pathology and Forensic Medicine (129 citations) and Cell Biology (118 citations). Eva Thomas has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Gabriel N. Hortobágyi, Aman U. Buzdar, Richard L. Theriault, Thomas A. Buchholz, S. Eva Singletary, Nuhad K. Ibrahim, Linda T. Vahdat, Marjorie C. Green, Terry L. Smith and Debra Frye. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Cancer, Supportive Care in Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.